← Scoopfeeds — Intelligent news, curated.
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
business

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Yahoo Finance · Jun 22, 2026, 2:35 PM · Also reported by 4 other sources

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Bloomberg Markets AbbVie to Buy Apogee Therapeutics for $10.9 Billion Investing.com AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says STAT News STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal

More in business

Investing.com
ECB’s Lagarde urges talks on yuan undervaluation
Investing.com
Judge blocks Trump’s use of revamped immigration database for voter checks
Investing.com
Form 144 SciSparc Ltd. For: 22 June
CNBC
Three key AI stocks to watch this week with traders expecting giant moves
Investing.com
Form 4 Texas Pacific Land Corp For: 22 June
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop